MedTrace Logo

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

NCT00347659 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2008-03-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of the Biologic Lung Volume Reduction System (BLVR) for patients with advanced emphysema.

Conditions

  • Pulmonary Emphysema

Interventions

DRUG

BLVR System

Treatment is administered in a single treatment session.

Sponsors & Collaborators

  • Aeris Therapeutics

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2006-12-31
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347659 on ClinicalTrials.gov